Hospital admissions in Spain with Wernicke encephalopathy as the main diagnosis rose by 128.9 per cent between 2016 and 2022, according to a retrospective study of the national Minimum Basic Data Set published in the Journal of Clinical Medicine on 15 February 2026. Researchers led by clinicians at the University Hospital of Salamanca identified 2,477 admissions coded E51.2 as the primary diagnosis over the seven years: 1,864 of the patients (75.2 per cent) were men, and the mean age was 58.2 years (standard deviation 11.0). The crude admission rate went from 0.45 per 100,000 inhabitants (211 admissions) in 2016 to 1.03 per 100,000 (495 admissions) in 2022, an average annual increase of 16 per cent (incidence rate ratio 1.16, 95 per cent confidence interval 1.14 to 1.18, p less than 0.001).

Wernicke encephalopathy is an acute syndrome caused by severe thiamine deficiency, and it is the emergency that can precede Korsakoff syndrome, the lasting amnesic disorder that families live with afterwards. The Spanish admissions were not brief. Mean length of stay was 19.0 days (standard deviation 36.5), 1,868 patients (75.4 per cent) were discharged home, and transfers to residential care rose across the period. In-hospital mortality was 3.7 per cent (91 deaths) and stayed broadly flat. In multivariable analysis, death was independently associated with active infection on admission (odds ratio 5.79, 95 per cent CI 3.39 to 9.89), cancer (OR 2.11, 95 per cent CI 1.18 to 3.79) and malnutrition (OR 1.64, 95 per cent CI 1.04 to 2.58), and odds rose steeply with the administrative risk of mortality index, from 3.45 at moderate to 38.76 at extreme.

That pattern, long stays and deaths driven by general medical illness rather than by the encephalopathy, is the practical point for ward teams and for relatives asking who is looking after the patient. The authors, who work in internal medicine, argue for early recognition of nutritional risk and a low threshold for considering the diagnosis in high risk groups. The database itself does not record which specialty admitted each patient, nor what treatment was given, so the study cannot say how thiamine was used or how many of these admissions later met criteria for Korsakoff syndrome. For that trajectory, the nearest comparable figure comes from a Swiss nationwide claims cohort of 4,393 admissions from 2012 to 2020, published in Mayo Clinic Proceedings in December 2023, in which 16.9 per cent of patients with alcohol related Wernicke encephalopathy went on to a coded diagnosis of Korsakoff syndrome.

A rising count in an administrative dataset can reflect rising illness, better coding, better recognition, or all three, and the Spanish authors do not separate those causes. What the record does establish is a larger annual caseload arriving through acute medical care, staying nearly three weeks, and going home to families in three cases out of four.